G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer.
about
GADD45gamma: a new vitamin D-regulated gene that is antiproliferative in prostate cancer cellsIdentification of a gadd45beta 3' enhancer that mediates SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor betaThe roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.Vitamin D suppresses leptin stimulation of cancer growth through microRNA.Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-downA novel function of the Fe65 neuronal adaptor in estrogen receptor action in breast cancer cellsVitamin D and the epigenome.Vitamin D and the RNA transcriptome: more than mRNA regulation.Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.Synergy of 1,25-dihydroxyvitamin D3 and carboplatin in growth suppression of SKOV-3 cells.Vitamin D and cancer: a review of molecular mechanismsAnticancer activity of VDR-coregulator inhibitor PS121912.1α,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrestInhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis.The coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hormone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells.The pleiotropic effects of vitamin D in gynaecological and obstetric diseases: an overview on a hot topicSuppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis.Suppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptorThe GADD45A (1506T>C) Polymorphism Is Associated with Ovarian Cancer Susceptibility and PrognosisRace/Ethnicity-Specific Association of Vitamin D and Global DNA Methylation: Cross-Sectional and Interventional Findings.Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer.Vitamin D receptor and RXR in the post-genomic era.Deficiency in TR4 nuclear receptor abrogates Gadd45a expression and increases cytotoxicity induced by ionizing radiationExpression of the Drosophila melanogaster GADD45 homolog (CG11086) affects egg asymmetric development that is mediated by the c-Jun N-terminal kinase pathway.1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498.Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin DThe vitamin D receptor as a therapeutic target.Vitamin D3 stimulates embryonic stem cells but inhibits migration and growth of ovarian cancer and teratocarcinoma cell linesThe vitamin D receptor in cancer.Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies1α,25(OH)₂D₃ Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal TransitionCirculating vitamin d and risk of epithelial ovarian cancer.Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.Vitamin D in cancer chemoprevention.Vitamin D: a custodian of cell signalling stability in health and disease.An ultraconserved Hox-Pbx responsive element resides in the coding sequence of Hoxa2 and is active in rhombomere 4.Suppression of Gadd45 alleviates the G2/M blockage and the enhanced phosphorylation of p53 and p38 in zinc supplemented normal human bronchial epithelial cells.
P2860
Q24600470-99F6A6D2-B26D-4888-B48C-2E584473BFEAQ28186138-8AB492F2-FABD-4A35-9EC2-A4E436E5E102Q30235880-EB263E22-968F-40D6-9399-A5B6AA5917B1Q30367127-89273E5C-DE22-4708-A66C-E1711677F83EQ33513312-D722E77D-F6DD-4197-BE6C-CC98E06C65EEQ33556060-34D25AA6-D971-457F-940B-CCDD97FE989CQ33569349-B93EB17F-16FB-4990-BEDB-6A293EFEF584Q33646923-C28668BE-8433-44E2-A583-03777DFFE6BAQ33802601-94C889F5-818A-4D54-A41F-D86432269E5CQ33942599-7FBDDB4E-85C8-430D-B60E-F8604E357610Q33967557-514A69EF-E2A7-43F2-AD49-3A54D6D4CD77Q34240570-EB637818-5811-4646-87CB-3E5721572BB8Q34253023-2962D3C2-A873-447D-8108-12BA0C8F8156Q34253178-280661D0-D649-4117-9305-AAD04FE96FBAQ34566030-CF41D73E-5239-4647-B91F-78D5EEFBFC42Q34795858-D7641BCE-B3D5-4344-A56C-5DE53E4111D2Q34949693-A06E95C4-D904-4D7E-9BA1-AEA5400570BFQ35591298-6B4D173A-3BB3-45C0-BA3C-3B78FE4CD201Q35646945-BA3AA851-13D0-43DA-A567-3BAE95F312FBQ35737779-9CC68815-729C-4643-8CD5-1731AEA9EF0FQ35793763-6716225F-3E1E-4F45-97EC-58B6463C2DA0Q35980777-A265C14E-F4CB-42E6-9F48-998C9202984BQ35989467-45C16978-AF1D-4308-84EF-3C72C6A3949BQ35999582-15D934CA-B278-4BA4-9891-3C6795430768Q36071737-43E36578-50AE-46EA-B9D0-213F2BD1CA4AQ36110722-CB673EA9-DB02-4D5B-B354-511F158A8519Q36287839-681445C7-8CE7-4305-9E69-E5362417099FQ36436094-2565EF41-181A-470F-A7BF-69D6D126CA37Q36508530-59A5CB69-32D9-425F-A92C-23B03CC1185CQ36596696-A4DC1CB3-3D36-48A2-96DA-2AF58709E2C7Q36810553-2C3BEB29-68FF-4552-B392-FC935F66E2F7Q37138638-1566D391-32AA-46CF-BFD6-5527780F626FQ37153564-D36CAA25-351A-4930-9893-4106A38FAEFBQ37210064-B32E7843-A409-4AC4-AD57-C3413753E113Q37326053-B4E3A20D-3F9F-4C15-A74A-EB85FC8F7645Q38338010-B921B983-2FA2-44E5-9D54-39164924407FQ38412880-634DD8F0-70B9-4B48-887B-D323FCB508B7Q38502035-8F33E09F-8A4D-458A-A2C5-963566416481Q39089311-254F2ABA-BB6F-477A-B8F1-8EA3FF3208CFQ40009409-D5A122BC-CB57-4179-A833-673DCF552EBD
P2860
G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
G2/M arrest by 1,25-dihydroxyv ...... GADD45 via an exonic enhancer.
@en
type
label
G2/M arrest by 1,25-dihydroxyv ...... GADD45 via an exonic enhancer.
@en
prefLabel
G2/M arrest by 1,25-dihydroxyv ...... GADD45 via an exonic enhancer.
@en
P2093
P2860
P356
P1476
G2/M arrest by 1,25-dihydroxyv ...... GADD45 via an exonic enhancer.
@en
P2093
Feng Jiang
Pengfei Li
Santo V Nicosia
Wenlong Bai
P2860
P304
48030-48040
P356
10.1074/JBC.M308430200
P407
P577
2003-09-23T00:00:00Z